Cart
sales@molnova.com
[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)
CAS No. ———
[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)( ——— )
Catalog No. M41076 CAS No. ———
[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product Name[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)
-
NoteResearch use only, not for human use.
-
Brief Description[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)
-
Description[Des-Leu26,Cys(Acm)20,31]-EGF (20-31)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number———
-
Formula Weight1430.61
-
Molecular FormulaC57H87N15O22S3
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
24-Norursodeoxycholi...
24-norursodeoxycholic acid is a side chain-shortened C23 homolog of UDCA.It has shown potent anti-inflammatory, anti-cholestatic, and anti-fibrotic properties.It is a Ursodeoxycholic Acid derivative. It is superior to Ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice24-norUrsodeoxycholic acid markedly improved liver tests and liver histology and significantly reduced hydroxyproline content and the number of infiltrating neutrophils and proliferating hepatocytes and cholangiocytes.?
-
Xylopentaose
Xylopentaose consists of five b-14 xylose sugars.
-
PF-05221304
PF-05221304 is an orally bioavailable, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), an enzyme that catalyzes the first committed step in de novo lipogenesis (DNL).
